Metodebevisregistrering
UCLA Prostate Cancer Index
The UCLA Prostate Cancer Index (UCLA PCI) is a 20-item, prostate-cancer-specific quality-of-life instrument focused on functional outcomes (urinary, sexual, bowel) rather than general cancer QoL. Developed by Litwin et al. in 1998, it has become the standard functional assessment tool in prostate cancer outcomes research, particularly for treatment comparison studies evaluating surgical vs. radiation outcomes.
Kilderegistrering
Citater kopieret ordret fra metodens kilderegistrering. Ingen påstandsniveauverifikation er udledt heraf.
UCLA Prostate Cancer Index
Taksonomisk metoderegistrering · process-pipeline / oncology
- Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., & Brook, R. H. (1998). The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care, 36(7), 1002–1012. · DOI 10.1097/00005650-199807000-00007
- Litwin, M. S., & Tan, H. J. (2017). The diagnosis and treatment of prostate cancer: a review. JAMA, 317(24), 2532–2542. · DOI 10.1001/jama.2017.7248
Kuraterede påstande
Påstande gemt i bevis-loggen, hver med sin egen vurdering.
Ingen kuraterede påstande endnu
Denne visning opfinder ikke en påstandsvurdering, når loggen ingen har.
Relaterede metoder
Genereret fra metodegrafen og vist som maskinelt foreslåede relationer — ingen bevispåstand er udledt.